Status:

COMPLETED

Bispectral Index and End-Tidal Anesthetic Gas Concentration in Pediatric Patients

Lead Sponsor:

Medtronic - MITG

Conditions:

Anesthesia

Eligibility:

All Genders

4-18 years

Phase:

NA

Brief Summary

The purpose of this study is to investigate the relationship between BIS™ values including EEG profile and anesthetic agents in the pediatric population

Detailed Description

This is a multi-center, prospective, observational, non-invasive, randomized controlled study to collect data to compare the performance of standard practice (SP) group with the BIS™ monitoring (BIS) ...

Eligibility Criteria

Inclusion

  • Pediatric Subjects (ASA physical status I or II or III) aged: 4 years to 18 years scheduled for procedures with sedation where the process of assessment will not interfere with the procedure, progress, or patient care

Exclusion

  • Has severe contact allergies that may cause a reaction to standard adhesive materials found in pulse oximetry sensors, ECG electrodes, respiration monitor electrodes, or other medical sensors
  • Known neurological disorder (e.g., epilepsy, the presence of a brain tumor, a history of brain surgery, hydrocephalic disorders, depression needing treatment with anti-depressive drugs, a history of brain trauma, hemiplegia, demyelinating disorders, cerebral palsy, congenital anomalies of the brain or spinal cord, or other known neurologic disorders)
  • Severe developmental delay per assessment of investigator or report of parent/guardian
  • Airway abnormalities
  • Pregnancy; subjects of childbearing potential will have a urine screen for pregnancy before surgery
  • If the process of assessment will interfere with the procedure or the progress of the procedure
  • Taking psychoactive medications
  • Taking any medications that may have an impact on the Central Nervous System (CNS)
  • Planned use of any regional anesthesia; a local field block is not included in this exclusion and can be used at the discretion of the anesthesia provider

Key Trial Info

Start Date :

July 2 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 12 2022

Estimated Enrollment :

209 Patients enrolled

Trial Details

Trial ID

NCT04810481

Start Date

July 2 2021

End Date

October 12 2022

Last Update

April 18 2023

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

Children's Hospital Colorado

Aurora, Colorado, United States, 80045

2

Lurie Children's Hospital of Chicago

Chicago, Illinois, United States, 60611

3

University of Minnesota

Minneapolis, Minnesota, United States, 55455

4

Rutgers University

Newark, New Jersey, United States, 07103